Put companies on watchlist
Vitrolife
ISIN: SE0011205202
WKN: A2JLT3
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Vitrolife · ISIN: SE0011205202 · PR Newswire (ID: 20241010IO28103)
10 October 2024 11:12AM

Conference call interim report


GOTHENBURG, Sweden, Oct. 10, 2024 /PRNewswire/ -- Invitation to attend Vitrolife AB (publ) conference call regarding presentation of the interim report Q3, 2024. The presentation will be held in English.

Time: Thursday 24 October, 2024 at 10.00 a.m. CET.

To attend the conference call, please use this link to register. After registration, you will be provided with telephone numbers, conference PIN, and personal PIN to access the conference. Your personal data will be processed in accordance with our privacy policy available at: Privacy policy | Vitrolife Group

Register for the call here

Vitrolife Group participants:

Bronwyn Brophy O´Connor, CEO

Patrik Tolf, CFO

The press release for the interim report will be released at 8.00 CET on the same day.

Before the conference call, presentation material will be available at the company web page.

A recorded version of the telephone conference will be available for seven days on number 

+44 (0) 20 3451 9993 (International), access code 5081758#.

Gothenburg, 10 October 2024

VITROLIFE AB (publ)

Contact: 

Patrik Tolf, CFO, phone +46 (0) 31 766 90 21

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/vitrolife-ab--publ-/r/conference-call-interim-report,c4049512

The following files are available for download:

https://mb.cision.com/Main/1031/4049512/3047214.pdf

Conference call interim report

 

Cision View original content:https://www.prnewswire.com/news-releases/conference-call-interim-report-302272770.html

SOURCE Vitrolife AB (publ)

Visual performance / price development - Vitrolife
Smart analysis and research tools can be found here.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2024
PR Newswire
Contact:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942